Looking after the NHS workforce must be a top priority, say experts
Looking after the NHS workforce is not only an ethical imperative but also a sound investment and must be a top priority, say experts in the third report… read more.
Looking after the NHS workforce is not only an ethical imperative but also a sound investment and must be a top priority, say experts in the third report… read more.
Dry Eye Disease (DED) is one of the more common eye diseases, affecting up to 30% of the world’s population. This disease can affect many different types of… read more.
Transdermal oestrogen products and the management of genitourinary syndrome of menopause are two important topics in menopause management. Selecting the most appropriate treatments should take into account individual… read more.
Abbott/Thoratec Corp. is recalling HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due to an issue called Extrinsic Outflow Graft Obstruction, (EOGO) . This happens when… read more.
Using artificial intelligence (AI) to supplement radiologists’ evaluations of mammograms may improve breast-cancer screening by reducing false positives without missing cases of cancer, according to a study by… read more.
Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from… read more.
Testosterone is an important hormone for women and may need replacement alongside oestrogen and progesterone, says Deborah Evans, pharmacist prescriber and Clinic Director at Remedi Health. Replacing testosterone… read more.
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that the FDA has approved Selarsdi (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to… read more.
No one associated with nursing homes – as residents or their families, friends, staff or administrators – is unaware of the massive impact of the pandemic on these… read more.
A University of Sydney study investigating menu items on major online food delivery outlets and applications (apps) in Australia has found most advertised items are missing nutritional information… read more.
The benefits of hormone replacement therapy (HRT) using transdermal devices are considerable, including a 30% reduction in all-cause mortality, according to Deborah Evans, prescribing pharmacist and Clinic Director… read more.
Roche announced that the FDA has approved Alecensa (alectinib) for adjuvant treatment following tumour resection for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours… read more.